Document is current
Any future updates will be listed below
-
Authors
Pietilä, Mika
Sahgal, Pranshu
Peuhu, Emilia http://orcid.org/0000-0003-4945-3046
Jäntti, Niklas Z.
Paatero, Ilkka http://orcid.org/0000-0001-5926-2396
Närvä, Elisa
Al-Akhrass, Hussein
Lilja, Johanna
Georgiadou, Maria
Andersen, Olav M.
Padzik, Artur
Sihto, Harri http://orcid.org/0000-0001-5265-5509
Joensuu, Heikki
Blomqvist, Matias
Saarinen, Irena
Boström, Peter J.
Taimen, Pekka
Ivaska, Johanna http://orcid.org/0000-0002-6295-6556
- License Information
-
More Information
Article History
Received: 7 May 2018
Accepted: 23 April 2019
First Online: 28 May 2019
Competing interests
: H.S. and H.J. own stocks of Sartar Therapeutics and are board members. H.J. has a co-appointment at Orion Pharma, and has received fees from Orion Pharma and Neutron Therapeutics Ltd. J.I., M.P., and P.S. have filed a patent application related to these findings. The remaining authors declare no competing interests.
